Semax

Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH). It has been investigated in laboratory and preclinical research for its interactions with neurochemical signaling, neurotrophic pathways, and cellular responses within the central nervous system.

Research Overview

Published and preclinical research involving Semax has explored areas including:

• Neurotrophic signaling pathways
• BDNF-related research models
• Neurotransmitter regulation
• Cellular responses to oxidative stress
• Neuroinflammatory signaling
• Learning and memory research models
• Cerebral blood-flow and neurological research models
• Cellular resilience and neuroprotection-related pathways

Semax remains an investigational research compound. Findings from laboratory, cellular, animal, or early-stage research should not be interpreted as demonstrating safety, effectiveness, or therapeutic benefit in humans.